Labat AfricaJSE:LAB +66.67% Median PS Value is R0.18 as of Jun. 25, 2026, which is 100% below its 10-year median of 0.86. The stock has 5 warning signs investors should review. Among 544 Drug Manufacturers companies, Labat Africa ranks better than 94.12% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Labat Africa's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2025 was R0.226. Labat Africa's 10-Year median PS Ratio is 0.7965. Therefore, the Median PS Value for today is R0.18.
As of today (2026-06-25), Labat Africa's share price is R0.05. Labat Africa's Median PS Value is R0.18. Therefore, Labat Africa's Price to Median PS Value for today is 0.28.
The historical rank and industry rank for Labat Africa's Median PS Value or its related term are showing as below:
JSE:LAB'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.18 Med: 0.86 Max: 2.55
Current: 0.28
During the past 13 years, the highest Price to Median PS Value of Labat Africa was 2.55. The lowest was 0.18. And the median was 0.86.
JSE:LAB's Price-to-Median-PS-Value is ranked better than 94.12% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.84
vs JSE:LAB: 0.28
Labat Africa (JSE:LAB) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Labat Africa's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.05
/
0.18
=
0.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labat Africa Median PS Value Related Terms
Labat Africa Median PS Value Historical Data
* Premium members only.
The historical data trend for Labat Africa's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:LAB vs ZTS, UTHR, VTRS: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Labat Africa's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.7965.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labat Africa's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2025 was R0.226.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labat Africa (JSE:LAB) has a Median PS Value of R0.18 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Labat Africa and its competitors. This is 79% below median its historical median of 0.86. Over the past decade, Labat Africa's Median PS Value has ranged from 0.18 to 2.55. According to the industry distribution chart, Labat Africa ranks #32 out of 544 companies in the Drug Manufacturers industry, placing it in the top 5.9%.
Is Labat Africa's Median PS Value too high?
Labat Africa's current Median PS Value of R0.18 is 79% below median its 10-year median of 0.86. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 2.55. Based on the distribution chart, Labat Africa ranks #32 out of 544 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Labat Africa's Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #32 out of 544 companies for Median PS Value. This places Labat Africa in the top 6% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.84. Historically, Labat Africa's own Median PS Value has ranged from 0.18 to 2.55 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.84, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current Median PS Value is R0.18, which is 79% below median its own 10-year median of 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current Median PS Value is R0.18, which is 79% below median its 10-year median of 0.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current Median PS Value is R0.18 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 